Skip to main content

Advertisement

Log in

Plasma Factors in Severe Early-Onset Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro

  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

Systemic endothelial dysfunction is a central feature in the pathophysiology of preeclampsia. Its cell biologic and molecular basis is poorly understood. One leading hypothesis argues that endothelial dysfunction is caused by (at present largely unknown) circulating factors released from the ischemic placenta. This study investigated the effects of plasma factors of severe, early-onset preeclamptic women versus healthy pregnant women on endothelial gene expression in vitro.

Methods

Plasma samples were taken from eight severe early-onset preeclamptic women and eight matched pregnant control women. Primary human umbilical vein endothelial cell (HUVEC) and human glomerular microvascular endothelial cell (hGMEC) cultures were incubated with 20% (vol/vol) plasma for 4, 12, and 24 hours. Identical amounts of RNA isolated from HUVEC from three preeclamptic and three control samples were pooled for each time point, and subsequently hybridized on human 60-mer oligonucleotide microarrays containing 17,000 genes. Gene expression levels of vascular cell adhesion molecule-1 (VCAM-1,), intercellular adhesion molecule-1 (ICAM-1,), interleukin-8 (IL-8), and interleukin-6 (IL-6) in HUVEC and hGMEC were quantified using real-time reverse transcription polymerase chain reaction (RT-PCR).

Results

Microarray analyses of individual genes identified no genes that were up- or down-regulated more than 2.7-fold, and analyses of gene ontologies showed no gene ontology significantly up- or down-regulated in HUVEC by preeclamptic plasma. IL-8 gene expression was modestly induced by preeclamptic plasma after 4, 12, and 24 hours of HUVEC and hGMEC incubation, as identified by real-time RT-PCR. The other genes analyzed did not show altered regulation by preeclamptic plasma factors.

Conclusions

In vitro, plasma from preeclamptic patients does not substantially alter endothelial gene expression profile. Only modest induction of IL-8 gene expression was observed. These results indicate that mechanisms other than soluble plasma constituents are likely involved in systemic endothelial cell activation in preeclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roberts JM. Pregnancy related hypertension. In: Creasy RK, Reyes A, eds. Maternal fetal medicine. Philadelphia: Saunders, 1998:835–72.

    Google Scholar 

  2. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359–72.

    Article  CAS  PubMed  Google Scholar 

  3. Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG. Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy; two different pathophysiological entities? Clin Sci (Lond) 2003;106:377–82.

    Article  Google Scholar 

  4. Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003;110:831–6.

    Article  CAS  PubMed  Google Scholar 

  5. Mastrogiannis DS, O’Brien WF, Krammer J, Benoit R. Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 1991;165:1711–6.

    Article  CAS  PubMed  Google Scholar 

  6. Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, Garcia-Paleta Y, Vital VS, Reyes A. Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol 2003;188:986–92.

    Article  CAS  PubMed  Google Scholar 

  7. Campbell DM, Campbell AJ. Evans Blue disappearance rate in normal and pre-eclamptic pregnancy. Clin Exp Hypertens B 1983;2:163–9.

    CAS  PubMed  Google Scholar 

  8. Kenny L, Baker PN. Maternal pathophysiology in pre-eclampsia. Baillieres Best Pract Res Clin Obstet Gynaecol 1999;13:59–75.

    Article  CAS  PubMed  Google Scholar 

  9. Friedman SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 1995;172:202–3.

    Article  CAS  PubMed  Google Scholar 

  10. Deng L, Bremme K, Hansson LO, Blomback M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994;84:941–5.

    CAS  PubMed  Google Scholar 

  11. Hsu CD, Copel JA, Hong SF, Chan DW. Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension. Obstet Gynecol 1995;86:897–9.

    Article  CAS  PubMed  Google Scholar 

  12. Rebelo I, Carvalho-Guerra F, Pereira-Leite L, Quintanilha A. Comparative study of lactoferrin and other blood markers of inflammatory stress between preeclamptic and normal pregnancies. Eur J Obstet Gynecol Reprod Biol 1996;64:167–73.

    Article  CAS  PubMed  Google Scholar 

  13. Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003;82:797–802.

    Article  PubMed  Google Scholar 

  14. Takacs P, Green KL, Nikaeo A, Kauma SW. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol 2003;188:740–4.

    Article  CAS  PubMed  Google Scholar 

  15. Velzing-Aarts FV, Muskiet FA, van der Dijs FP, Duits AJ. High serum interleukin-8 levels in Afro-Caribbean women with preeclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol 2002;48:319–22.

    PubMed  Google Scholar 

  16. Kauma S, Takacs P, Scordalakes C, Walsh S, Green K, Peng T. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gyencol 2002;100:706–14.

    CAS  Google Scholar 

  17. Redman CW, Sacks GP, Sargent IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gyencol 1999;180:499–506.

    Article  CAS  Google Scholar 

  18. Faas MM, Schuiling GA. Pre-eclampsia and the inflammatory response. Eur J Obstet Gyencol Reprod Biol 2001;95:213–7.

    Article  CAS  Google Scholar 

  19. Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gyencol Reprod Biol 1997;71:53–8.

    Article  CAS  Google Scholar 

  20. Chaiworapongsa T, Romero R, Yoshimatsu J, et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med 2002;12:19–27.

    Article  CAS  PubMed  Google Scholar 

  21. Phocas I, Rizos D, Papoulias J, Xyni K, Sarandakou A, Salamalekis E. A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia. J Perinatol 2000;20:114–9.

    Article  CAS  PubMed  Google Scholar 

  22. VanWijk MJ, Kublickiene K, Boer K, Van Bavel E. Vascular function in preeclampsia. Cardiovasc Res 2000;47:38–48.

    Article  CAS  PubMed  Google Scholar 

  23. Baker PN, Davidge ST, Barankiewicz J, Roberts JM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 1996;27:56–61.

    Article  CAS  PubMed  Google Scholar 

  24. Taylor RN, Musci TJ, Rodgers GM, Roberts JM. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am J Reprod Immunol 1991;25:105–8.

    Article  CAS  PubMed  Google Scholar 

  25. Endresen MJ, Morris JM, Nobrega AC, Buckley D, Linton EA, Redman CW. Serum from preeclamptic women induces vascular cell adhesion molecule-1 expression on human endothelial cells in vitro: A possible role of increased circulating levels of free fatty acids. Am J Obstet Gyencol 1998;179:665–70.

    Article  CAS  Google Scholar 

  26. Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: The endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig 1999;6:3–10.

    CAS  PubMed  Google Scholar 

  27. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 2001;15:279–81.

    Article  CAS  PubMed  Google Scholar 

  28. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV.

    Article  CAS  PubMed  Google Scholar 

  29. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143–8.

    Article  Google Scholar 

  30. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gyencol 1996;175:460–4.

    Article  CAS  Google Scholar 

  31. Janssen S, Limburg PC, Bijzet J, et al. SAA versus CRP in chronic inflammatory diseases. In: Peeters H, ed. Protides of the biological fluids. Oxford, UK: Pergamon Press, 1986:347–50.

    Google Scholar 

  32. Xiang CC, Kozhich OA, Chen M, et al. Amine-modified random primers to label probes for DNA microarrays. Nat Biotechnol 2002;20:738–42.

    Article  CAS  PubMed  Google Scholar 

  33. Trentani A, Kuipers SD, te Meerman GJ, Beekman J, ter Horst GJ, den Boer JA. Immunohistochemical changes induced by repeated footshock stress: Revelations of gender-based differences. Neurobiol Dis 2003;14:602–18.

    Article  CAS  PubMed  Google Scholar 

  34. Mutin M, Dignat-George F, Sampol J. Immunologic phenotype of cultured endothelial cells: Quantitative analysis of cell surface molecules. Tissue Antigens 1997;50:449–58.

    Article  CAS  PubMed  Google Scholar 

  35. Asgeirsdottir SA, Kok RJ, Everts M, Meijer DK, Molema G. Delivery of pharmacologically active dexamethasone into activated endothelial cells by dexamethasone-anti-E-selectin immunoconjugate. Biochem Pharmacol 2003;65:1729–39.

    Article  CAS  PubMed  Google Scholar 

  36. McCormick SM, Eskin SG, McIntire LV, et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2001;98:8955–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Murakami T, Mataki C, Nagao C, et al. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J Atheroscler Thromb 2000;7:39–44.

    Article  CAS  PubMed  Google Scholar 

  38. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995;102:20–5.

    Article  CAS  PubMed  Google Scholar 

  39. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gyencol 1994;170:1752–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rogier B. Donker MSc.

Additional information

This study was financially supported by the Jan Kornelis de Cock Foundation and the Jan Dekker & Dr. Ludgardine Bouwman Foundation. The authors thank Henk Moorlag and Naomi Werner, Department of Pathology and Laboratory Medicine, for their expert technical assistance, and Robert M. W. Hofstra, PhD, Department of Medical Genetics, Piet C. Limburg, PhD, Department of Clinical Immunology, Anke van den Berg, PhD, and Marijke M. Faas, PhD, Department of Pathology and Laboratory Medicine, for their participation in discussing study design and results.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Donker, R.B., Ásgeirsdóttir, S.A., Gerbens, F. et al. Plasma Factors in Severe Early-Onset Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro. Reprod. Sci. 12, 98–106 (2005). https://doi.org/10.1016/j.jsgi.2004.10.014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.jsgi.2004.10.014

Key words

Navigation